{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:50:57Z","timestamp":1648648257437},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00393-014-1371-6","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T13:36:48Z","timestamp":1398346608000},"page":"836-842","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnose und Therapiestandard der Gicht in \u00d6sterreich"],"prefix":"10.1007","volume":"73","author":[{"given":"J.","family":"Sautner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,26]]},"reference":[{"key":"1371_CR1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A et al (2013) Vascular and upper gastrointestinal effects of non-steroidal antiinflammatory drugs: meta-analysis of individual participant data from randomised trials. Lancet 382:769\u2013779","journal-title":"Lancet"},{"key":"1371_CR2","first-page":"2429","volume":"31","author":"Borstad","year":"2004","unstructured":"Borstad GC, Bryant LR, Abel MP et al (2004) Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 31:2429\u20132432","journal-title":"J Rheumatol"},{"key":"1371_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","volume":"336","author":"Choi","year":"2008","unstructured":"Choi HK, Curhan G (2008) Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 336:309\u2013312","journal-title":"BMJ"},{"key":"1371_CR4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard.2007.071530","volume":"66","author":"Doherty","year":"2007","unstructured":"Doherty M, Bardin T, Pascual E (2007) International survey on the diagnosis and management of gout. Ann Rheum Dis 66:1685\u20131686","journal-title":"Ann Rheum Dis"},{"key":"1371_CR5","doi-asserted-by":"crossref","unstructured":"Duftner C, Schueller-Weidekamm C, Mandl C et al (2013) Clinical implementation of musculoskeletal ultrasound in rheumatology in Austria. Rheumatol Int. DOI 10.1007\/s00296-013-2863-4","DOI":"10.1007\/s00296-013-2863-4"},{"key":"1371_CR6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11926-010-0154-6","volume":"13","author":"Edwards","year":"2010","unstructured":"Edwards NL (2010) Quality of care in patients with gout: why is management suboptimal and what can be done about it? Curr Rheumatol Rep 13:154\u2013159","journal-title":"Curr Rheumatol Rep"},{"key":"1371_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jbspin.2012.01.004","volume":"79","author":"Garay","year":"2012","unstructured":"Garay RP, El-Gewely MR, Labaune JP, Richette P (2012) Therapeutic perspectives on uricases for gout. Joint Bone Spine 79:237\u2013242","journal-title":"Joint Bone Spine"},{"key":"1371_CR8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2011.09.042","volume":"109","author":"Kaya","year":"2012","unstructured":"Kaya MG, Uyarel H, Akpek M et al (2012) Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 109:486\u2013491","journal-title":"Am J Cardiol"},{"key":"1371_CR9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP et al (2012) 2012 ACR guidelines for management of gout. Part I: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64:1431\u20131446","journal-title":"Arthritis Care Res"},{"key":"1371_CR10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD et al (2012) 2012 ACR guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64:1447\u20131461","journal-title":"Arthritis Care Res"},{"key":"1371_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","volume":"49","author":"Kuo","year":"2010","unstructured":"Kuo CF, See LC, Luo SF et al (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 49:141\u2013146","journal-title":"Rheumatology"},{"key":"1371_CR12","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1136\/annrheumdis-2013-204108","volume":"72","author":"Mathieu","year":"2013","unstructured":"Mathieu S, Pereira B, Couderc M, Soubrier M (2013) Usefulness of ultrasonography in the diagnosis of gout: a meta-analysis. Ann Rheum Dis 72:e23. DOI 10.1136\/annrheumdis_2013-204108","journal-title":"Ann Rheum Dis"},{"key":"1371_CR13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","volume":"44","author":"Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar TJ, Bilker WB et al (2005) Suboptimal physician adherence to quality indicators fort he management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology 44:1038\u20131042","journal-title":"Rheumatology"},{"key":"1371_CR14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2007.078469","volume":"66","author":"Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Why ist gout so poorly managed? Ann Rheum Dis 66:1269\u20131270","journal-title":"Ann Rheum Dis"},{"key":"1371_CR15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","volume":"47","author":"Perez","year":"2002","unstructured":"Perez\u2010Ruiz F, Calabozo M, Pijoan JI et al (2002) Effect of urate\u2010lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 47:356\u2013360","journal-title":"Arthritis Rheum"},{"key":"1371_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","volume":"5","author":"Perez-Ruiz","year":"1999","unstructured":"Perez-Ruiz F, Calabozo M, Fernandez-Lopez MJ et al (1999) Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study. J Clin Rheumatol 5:49\u201355","journal-title":"J Clin Rheumatol"},{"key":"1371_CR17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00393-010-0704-3","volume":"69","author":"Puchner","year":"2010","unstructured":"Puchner R (2010) Job satisfaction and future prospects among Austrian rheumatologists. Z Rheumatol 69:818\u2013829","journal-title":"Z Rheumatol"},{"key":"1371_CR18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ard.2007.085902","volume":"67","author":"Reinders","year":"2008","unstructured":"Reinders MK, Jansen TL (2008) Survey on management of gout among Dutch rheumatologists. Ann Rheum Dis 67:1049","journal-title":"Ann Rheum Dis"},{"key":"1371_CR19","first-page":"255","volume":"63","author":"Rozenberg","year":"1996","unstructured":"Rozenberg S, Lang T, Laatar A et al (1996) Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists. Rev Rhum Engl Ed 63:255\u2013261","journal-title":"Rev Rhum Engl Ed"},{"key":"1371_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-64-2-229","volume":"64","author":"Rundles","year":"1966","unstructured":"Rundles RW, Metz EN, Silberman HR (1966) Allopurinol in the treatment of gout. Ann Intern Med 64:229\u2013258","journal-title":"Ann Intern Med"},{"key":"1371_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00508-013-0469-1","volume":"126","author":"Sautner","year":"2014","unstructured":"Sautner J, Gruber J, Herold M et al (2014) Austrian 3e-recommendations for diagnosis and management of gout 2013. Wien Klin Wochenschr 126:79-89","journal-title":"Wien Klin Wochenschr"},{"key":"1371_CR22","first-page":"2050","volume":"33","author":"Schlesinger","year":"2006","unstructured":"Schlesinger N, Moore DF, Sun JD, Schumacher HR Jr (2006) A survey of current evaluation and treatment of gout. J Rheumatol 33:2050\u20132052","journal-title":"J Rheumatol"},{"key":"1371_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","volume":"73","author":"Sivera","year":"2013","unstructured":"Sivera F, Andres M, Carmona L et al (2013) Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 73:328\u2212335","journal-title":"Ann Rheum Dis"},{"key":"1371_CR24","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3272","volume":"13","author":"Soriano","year":"2011","unstructured":"Soriano LC, Rothenbacher D, Choi HK, Rodriguez LA (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 13:R39","journal-title":"Arthritis Res Ther"},{"key":"1371_CR25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K et al (2010) High versus low dosing of oral colchicine for early acute gout flare: 24h outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62:1060\u20131068","journal-title":"Arthritis Rheum"},{"key":"1371_CR26","first-page":"621","volume":"55","author":"Vazquez-Mellado","year":"2003","unstructured":"Vazquez-Mellado J, Espinoza J, Hernandez-Garduno A et al (2003) Diagnosis and treatment of gout in Mexiko City. Results from a physicians survey. Rev Invest Clin 55:621\u2013628","journal-title":"Rev Invest Clin"},{"key":"1371_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-5381-6_3","volume":"431","author":"Yamanaka","year":"1998","unstructured":"Yamanaka H, Togashi R, Hakoda M et al (1998) Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti\u2010hyperuricemic treatment. Adv Exp Med Biol 431:13\u201318","journal-title":"Adv Exp Med Biol"},{"key":"1371_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clinthera.2012.12.011","volume":"35","author":"Ye","year":"2013","unstructured":"Ye P, Yang S, Zhang W et al (2013) Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis. Clin Ther 35:180\u2013189","journal-title":"Clin Ther"},{"key":"1371_CR29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311","journal-title":"Ann Rheum Dis"},{"key":"1371_CR30","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1371-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1371-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:18Z","timestamp":1559061378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1371-6"}},"subtitle":["Umfrage unter Ber\u00fccksichtigung der EULAR-Empfehlungen"],"short-title":[],"issued":{"date-parts":[[2014,4,26]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1371-6","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,26]]}}}